In the rapidly evolving landscape of advanced biochemical research, MTP 131—frequently referred to as SS-31 or Elamipretide—has emerged as a focal point for those interested in cellular bioenergetics. As an enthusiast documenting my own by HN Sabbah·2016·Cited by 222—Background—Elamipretide (MTP-131), a novel mitochondria-targetingpeptide, was shown to reduce infarct size in animals with myocardial infarction and improve Read more exploration into research compounds, I find the science behind this specific molecule to be one of the most fascinating developments in recent years. Whether you are searching for MTP-131 for laboratory study or are simply curious about how these compounds function, understanding the nuances of this mitochondria-targeted peptide MTP-131 is essential.
What Exactly is MTP 131?
At its core, MTP 131 is a small peptide, specifically a synthetic tetrapeptide with a cationic 3+ charge at physiological pH. This unique chemical structure is what allows it to selectively accumulate within the inner mitochondrial membrane. For those unfamiliar with the terminology, it is important to note that MTP-131 and SS-31 are the exact same peptide. It is also known MTP 131 is a mitochondria-targeted peptide antioxidant. It localizes to the mitochondria and reduces tert-butyl hydroperoxide-induced lipid peroxidation Read more by the development name Elamipretide (formerly MTP 131).
When I first began researching this compound, I learned that it is a tetrapeptide compound being developed by Stealth Therapeutics. The primary interest among researchers is its role as an efficacious antioxidant that is a mitochondria-targeting peptide. By localizing specifically to the mitochondria, it helps in restoring mitochondrial superoxide levels with Elamipretide (MTP-131), which is critical for maintaining cellular homeostasis.
The Role of Mitochondria-Targeted Technology
The interest in peptides—and specifically this class of molecules—stems from their ability to interact with cellular structures at a granular level. Many researchers are drawn to the potential of these compounds because they emerge as a promising candidate in combating mitochondrial dysfunction-relate Is this mitochondria's big moment? d disorders.
In my own review of the literature, I have observed that MTP 131 is a mitochondria-targeted peptide antioxidant that has been studied in various contexts. For example, it is currently being investigated in several Phase 2 clinical trials for heart failure. Furthermore, it is noteworthy that there is a Global Phase 3 Clinical Program for Elamipretide currently underway, highlighting the significant investment in this technology.
Practical Considerations for Research Use
If you are looking into sourcing these compounds, it is clear t Elamipretide (aka Bendavia, MPT-131, and SS31)is a tetrapeptide with a cationic 3 + charge at physiological pHthat is currently in clinical development for Read more hat SS-31 peptide, also known as Elamipretide, Bendavia, or MTP-131, is available for research purposes from multiple suppliers. As someone who values quality, I always emphasize that the integrity of the pe NCT02367014 | Safety, Tolerability, and Efficacy of MTP- ptide sequence (D-Arg-Dmt-Lys-Phe-NH2) is paramount for any experimental outcome.
It is interesting to follow the regulatory journey of these molecules. We have seen news regarding the FDA approval of Stealth's mitochondria-targeted therapy, which has sparked widespread discussion about the future of Stealth BioTherapeutics' pipeline. While Elamipretide (MTP-131, SS-31) has been recognized for its potential, it is also important to r Chronic Therapy With Elamipretide (MTP-131), a Novel emember that it is a medication used for the treatment of Barth syndrome, which underscores the serious nature of the research being conducted.
Final Thoughts on the Future of MTP 131
The fascination with 131 and its related compounds will likely continue as more data is published. My experience with these peptides has shown me that the precision with which they target the "powerhouse of the cell" is what sets them apart from conventional antioxidants. Whether it is through the lens of longevity research or the study of metabolic efficiency, the NCT02367014 | Safety, Tolerability, and Efficacy of MTP- work surrounding MTP remains at the forefront of modern biochemical inquiry.
As with any advanced research material, ensure you are sourcing from reputable suppliers who provide high-purity, verified products. Understanding that MTP-131 is a specialized tool for mitochondrial research is the first step toward a deeper appreciation of this complex and evolving field.